Merck ASCO Conference Presentation 2016

Merck & Co., Inc. presented at the ASCO (American Society of Clinical Oncology) event on June 6, 2016. The presentation outlined the company's strategy overview, combination therapy strategy, and biomarker strategy in oncology development. Forward-looking statements detail pipeline products and regulatory approvals under discussion.